Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

AVBP
ArriVent BioPharma, Inc. Common Stock
stock NASDAQ

At Close
Oct 2, 2026 3:59:48 PM EDT
28.30USD-2.178%(-0.63)511,587
24.12Bid   31.50Ask   7.38Spread
Pre-market
Oct 2, 2026 8:50:30 AM EDT
29.25USD+1.106%(+0.32)104
After-hours
Oct 2, 2026 4:39:30 PM EDT
28.27USD-0.106%(-0.03)200
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrends
AVBP Reddit Mentions
Subreddits
Limit Labels     

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.
Take me to the API
AVBP Specific Mentions
As of Oct 3, 2026 12:07:25 AM EDT (1 min. ago)
Includes all comments and posts. Mentions per user per ticker capped at one per hour.
22 days ago • u/Zipski577 • r/biotech_stocks • new_to_smallcap_biotech_investing_whats_the_plan • C
PHVS, DNTH, RLAY, ABVX, TVTX, DFTX, INSM, AVBP, PBLS and some riskier smaller companies I own RZLT, CATX, and IPSC.
Nothing is guaranteed to be successful. 90% of drugs that enter human clinical trials fail and for those that get approved, 90% of the time consensus forecasts for new drug launches end up being wrong. A lot of these are later stage or already had successful ph3s or approved drugs, and could still have a number of things go wrong.
If SLS has such a high chance of succeeding and already a foregone conclusion, then why is 30-40% of the float short with not a single biotech specialist hedge fund holding this stock? That doesn’t mean it will fail, but should raise more ppls concerns and questions about if it’s really 99% likely to succeed if people with way more experience and knowledge not only don’t believe in this, but are actively betting against it.
And if the trial successfully achieves stat sig on its primary endpoint then there is still no guarantee whatsoever it would ll just “get bought out.” There is way too many assumptions being made by people on Reddit. A lot of people also started to believe GameStop and beyond meat would turn their businesses around.
sentiment 0.90
22 days ago • u/Zipski577 • r/biotech_stocks • new_to_smallcap_biotech_investing_whats_the_plan • C
PHVS, DNTH, RLAY, ABVX, TVTX, DFTX, INSM, AVBP, PBLS and some riskier smaller companies I own RZLT, CATX, and IPSC.
Nothing is guaranteed to be successful. 90% of drugs that enter human clinical trials fail and for those that get approved, 90% of the time consensus forecasts for new drug launches end up being wrong. A lot of these are later stage or already had successful ph3s or approved drugs, and could still have a number of things go wrong.
If SLS has such a high chance of succeeding and already a foregone conclusion, then why is 30-40% of the float short with not a single biotech specialist hedge fund holding this stock? That doesn’t mean it will fail, but should raise more ppls concerns and questions about if it’s really 99% likely to succeed if people with way more experience and knowledge not only don’t believe in this, but are actively betting against it.
And if the trial successfully achieves stat sig on its primary endpoint then there is still no guarantee whatsoever it would ll just “get bought out.” There is way too many assumptions being made by people on Reddit. A lot of people also started to believe GameStop and beyond meat would turn their businesses around.
sentiment 0.90


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC